Orchard Therapeutics logo

Executive Director, Regulatory Science

Orchard Therapeutics

Cambridge, MAHybridPosted 1 day ago$285,000 - $350,000/year
Full TimeDirector & AboveRegulatory AffairsBiotechnology
Original posting ↗

Summary

Location: Hybrid, Cambridge (MA) or Remote, US Eastern. Reporting to: VP, Regulatory Science.

Job description

Job Summary

The Executive Director (ED), Regulatory Science plays a pivotal role in ensuring global alignment on regulatory strategies to meet corporate goals across Orchard's investigational and approved ex vivo HSC gene therapies throughout the different phases of lifecycle (i.e. development, registration and post-approval). As a US Regulatory Science subject matter expert, this position is instrumental in optimizing US regulatory strategies, maintaining high submission standards and fostering strong, collaborative relationships with the US FDA.

Strategic Leadership & FDA Interactions

  • Serve as senior advisor actively supporting the assigned US Regulatory Lead (US RL) and the Program Regulatory Teams defining optimized US regulatory strategies across the entire pipeline
  • Closely collaborate with the Global Regulatory Lead (GRL), the Regulatory CMC team and the VP of Regulatory Science, to ensure a consistent global approach is used for the development and execution of regulatory strategies
  • Oversee preparation of US regulatory documentation; review meeting requests/briefing documents and other strategic regulatory filings to FDA across programs (e.g. INDs, orphan/fast track/RMAT designation requests, BLAs)
  • Provide oversight and guidance to US RLs, in preparation of Orchard's cross-functional teams for FDA meetings, supporting meeting conduct, and ensuring effective communication with the Agency across programs
  • Leverage experience and insights to anticipate FDA's reactions, interpret Agency's requests and develop actionable proactive risk-mitigation plans
  • Lead/manage post-approval activities and commitments for Lenmeldy® in compliance with FDA requirements

Regulatory Intelligence & Compliance

  • Actively participate in Regulatory intelligence and support Regulatory policy activities, with a focus on US topics
  • Monitoring, identification, assessment, impact analysis and dissemination of relevant regulatory and competitive landscape updates
  • Participation in relevant US/international industry associations discussions to advocate on critical pieces of regulation for Orchard's portfolio
  • Accountable for ensuring team's adherence to GxP, as well as all relevant Orchard policies and SOPs
  • Oversee the implementation of new applicable US regulations relevant to development programs
  • Oversee the US Regulatory Lead activities for FDA inspection readiness

People & Resource Management

  • Line management and mentoring of a team of 3-5 regulatory professionals, supporting their individual development plans
  • Optimize resources by partnering with the VP, Regulatory Science to define headcount needs, lead recruitments, and manage external vendors
  • Manage budget targets, and contribute to the development of the department's annual operating plan (AOP)

Flexible Duties

  • May act as GRL/US RL on specific program(s) if necessary
  • Represent the regulatory function on related cross-functional program team(s)
  • Partner with the program lead and development team to build development strategy intended to support regulatory approval(s)
  • Collaborate closely with the Reg CMC lead for the development of successful regulatory strategy associated with the CMC development
  • Lead the program regulatory team towards the execution of all planned and relevant regulatory activities globally
  • Regulatory liaison with academic partners and coordination of regulatory activities with them as appropriate
  • May participate in business development initiatives for new programs if relevant
  • International travels (mostly to the UK/EU) as needed

Requirements

  • PharmD or PhD in a scientific discipline preferred
  • 15+ years of hands-on Regulatory Affairs experience in biotech
  • Experience spanning US regulatory science activities across drug lifecycle phases (development, registration, post-approval)
  • Experience with FDA meetings, INDs, regulatory designations and expedited programs (orphan, fast track, RMAT, breakthrough, accelerated approval)
  • Experience with pediatric study plans, BLA/NDA, post-approval modifications, annual reports and supplements
  • Proven success leading major FDA interactions (Pre-IND, EOP2, Pre-BLA, Advisory Committees)
  • Experience managing expedited pathways (RMAT, Accelerated Approval)
  • Strong knowledge of orphan drugs development and registration regulations
  • Knowledge of pediatric drug development and registration
  • Knowledge of preclinical and clinical development of cell and gene therapies
  • In-depth mastery of FDA guidelines relevant for development of ATMPs in rare/pediatric diseases
  • Familiarity with EMA regulations highly desired
  • Managerial experience
  • Knowledge of US MLR review of AdPromo materials a plus
  • Recent experience leading a successful BLA submission resulting in accelerated approval a major plus

Company overview

Orchard Therapeutics is a global biotechnology company specializing in hematopoietic stem cell (HSC) gene therapy for rare inherited diseases. Founded in 2015 and now a subsidiary of Kyowa Kirin, the company focuses on developing potentially curative treatments for severe genetic conditions including immunological disorders, neurometabolic and neurodegenerative diseases. Their pioneering approach involves genetically modifying a patient's own blood stem cells outside the body and reinserting them to correct the underlying cause of disease with a single treatment. The company's lead product, Libmeldy (atidarsagene autotemcel), is approved for metachromatic leukodystrophy (MLD), while their pipeline includes investigational therapies for mucopolysaccharidosis type I, type IIIA, frontotemporal dementia, and Crohn's disease. Headquartered in London with operations across Europe and the United States, Orchard Therapeutics combines decades of research expertise with a patient-centric approach to transform the treatment paradigm for rare genetic diseases. The company operates with approximately 51-200 employees and maintains a strong commitment to advancing gene therapy technology from promising scientific concepts to life-transforming clinical realities.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.